<h1>Global genomics firm names new Head of AMEA to drive commercial access and regional growth across life sciences</h1> A global genomics company announced the appointment of a senior executive as Head of AMEA, effective immediately; the appointee brings over 25 years' leadership in medical technology and life sciences with prior senior roles at major industry firms and most recently served as VP & GM for emerging markets at a healthcare supplier, where they led commercial, operational and manufacturing strategies across APAC and Latin America and drove regional transformation and growth. The executive will be based in Singapore, succeeds the interim regional head (who will continue as Head of Europe), and is expected to expand commercial access to genomic technologies across AMEA.